본문 바로가기
KERD
논문KCI 등재

Zoster sine herpete: a review

Song Cao|Junli Zhou|Juan Li|Lulin Ma
대한통증학회 (The Korean Pain Society)|2020.07|The Korean Journal of Pain|제33권 제3호|pp. 208-215|DOI 10.3344/kjp.2020.33.3.208

2

조회

0

다운로드

5

인용

0

참고문헌

키워드

DiagnosisHumanHerpes ZosterNeuralgiaTherapeuticsInfectionsHerpesvirus 3PostherpeticAntiviral AgentsVirus DiseasesZoster Sine Herpete.

초록

Zoster sine herpete (ZSH) is one of the atypical clinical manifestations of herpes zoster (HZ), which stems from infection and reactivation of the varicella-zoster virus (VZV) in the cranial nerve, spinal nerve, viscera, or autonomic nerve. Patients with ZSH display variable symptoms, such as neuralgia, however, different from HZ, ZSH show no zoster, which makes clinical diagnosis difficult. ZSH not only causes initial symptoms, such as neuropathic pain in the affected nerve, Bell palsy, and Ramsay Hunt syndrome, but also postherpetic neuralgia and fatal complications such as VZV encephalitis and stroke. The misdiagnosis of ZSH and tardy antiviral treatment may lead to severe ZSH sequelae. We review the publications related to ZSH, especially its diagnosis with VZV DNA and/or anti-VZV immunoglobulin (IgG and IgM). More work about ZSH, especially ZSH epidemiological survey and guidelines for its diagnosis and treatment, are needed because most of the present studies are case reports.

Abstract

Zoster sine herpete (ZSH) is one of the atypical clinical manifestations of herpes zoster (HZ), which stems from infection and reactivation of the varicella-zoster virus (VZV) in the cranial nerve, spinal nerve, viscera, or autonomic nerve. Patients with ZSH display variable symptoms, such as neuralgia, however, different from HZ, ZSH show no zoster, which makes clinical diagnosis difficult. ZSH not only causes initial symptoms, such as neuropathic pain in the affected nerve, Bell palsy, and Ramsay Hunt syndrome, but also postherpetic neuralgia and fatal complications such as VZV encephalitis and stroke. The misdiagnosis of ZSH and tardy antiviral treatment may lead to severe ZSH sequelae. We review the publications related to ZSH, especially its diagnosis with VZV DNA and/or anti-VZV immunoglobulin (IgG and IgM). More work about ZSH, especially ZSH epidemiological survey and guidelines for its diagnosis and treatment, are needed because most of the present studies are case reports.

참고문헌 (81)

  1. Dayan RR, "Herpes zoster-typical and atypical presentations", Postgrad Med, 129, pp.567~571 (2017)
  2. Nagel MA, "The protean neurologic manifestations of varicella-zoster virus infection", Cleve Clin J Med, 74, pp.489~494 (2007)
  3. Kennedy PGE, "Clinical features of varicellazoster virus infection", Viruses, 10, pp.609~ (2018)
  4. Young Hoon Jeon, "Herpes Zoster and Postherpetic Neuralgia: Practical Consideration for Prevention and Treatment", The Korean Journal of Pain, 28(3), pp.177~184 (2015), 대한통증학회
  5. Lewis GW, "Zoster sine herpete", Br Med J, 2, pp.418~421 (1958)
  6. Drago F, "Acute pain and postherpetic neuralgia related to varicella zoster virus reactivation : comparison between typical herpes zoster and zoster sine herpete", J Med Virol, 91, pp.287~295 (2019)
  7. Ibraheem M, "Fatal wild-type varicella-zoster virus encephalitis without a rash in a vaccinated child", Pediatr Infect Dis J, 32, pp.183~185 (2013)
  8. Chen WH, "Zoster sine herpete, vertebral artery stenosis, and ischemic stroke", J Stroke Cerebrovasc Dis, 22, pp.e234~7 (2013)
  9. Weaver BA, "Herpes zoster overview : natural history and incidence", J Am Osteopath Assoc, 109(6 Suppl 2), pp.S2~6 (2009)
  10. Takao Y, "Incidences of herpes zoster and postherpetic neuralgia in Japanese adults aged 50 years and older from a communitybased prospective cohort study : the SHEZ study", J Epidemiol, 25, pp.617~625 (2015)
  11. Yang F, "The epidemiology of herpes zoster and postherpetic neuralgia in China : results from a cross-sectional study", Pain Ther, 8, pp.249~259 (2019)
  12. Tseng HF, "The epidemiology of herpes zoster in immunocompetent, unvaccinated adults ≥50 years old: incidence, complications, hospitalization, mortality, and recurrence", J Infect Dis (2019)[DOI]
  13. Johnson RW, "Clinical practice. Postherpetic neuralgia", N Engl J Med, 371, pp.1526~1533 (2014)
  14. Kawai K, "Systematic review of incidence and complications of herpes zoster : towards a global perspective", BMJ Open, 4, pp.e004833~ (2014)
  15. Kawai K, "Increasing incidence of herpes zoster over a 60-year period from a populationbased study", Clin Infect Dis, 63, pp.221~226 (2016)
  16. Gershon AA, "Advances in the understanding of the pathogenesis and epidemiology of herpes zoster", J Clin Virol, 48(Suppl 1), pp.S2~7 (2010)
  17. Koshy E, "Epidemiology, treatment and prevention of herpes zoster : a comprehensive review", Indian J Dermatol Venereol Leprol, 84, pp.251~262 (2018)
  18. Sauerbrei A, "Diagnosis, antiviral therapy, and prophylaxis of varicella-zoster virus infections", Eur J Clin Microbiol Infect Dis, 35, pp.723~734 (2016)
  19. Gershon AA, "Varicella zoster virus infection", Nat Rev Dis Primers, 1, pp.15016~ (2015)
  20. McDonald JR, "Herpes zoster risk factors in a national cohort of veterans with rheumatoid arthritis", Clin Infect Dis, 48, pp.1364~1371 (2009)
  21. Laemmle L, "Modeling varicella zoster virus persistence and reactivation-closer to resolving a perplexing persistent state", Front Microbiol, 10, pp.1634~ (2019)
  22. Arvin A, "Aging, immunity, and the varicella-zoster virus", N Engl J Med, 352, pp.2266~2267 (2005)
  23. Wang JP, "Varicella-zoster virus activates inflammatory cytokines in human monocytes and macrophages via Tolllike receptor 2", J Virol, 79, pp.12658~12666 (2005)
  24. Hevner R, "An unusual cause of trigeminal-distribution pain and tumour", Lancet Neurol, 2, pp.567~571 (2003)
  25. Birlea M, "Varicella-zoster virus trigeminal ganglioneuritis without rash", Neurology, 82, pp.90~92 (2014)
  26. Zerboni L, "Neuronal subtype and satellite cell tropism are determinants of varicella-zoster virus virulence in human dorsal root ganglia xenografts in vivo", PLoS Pathog, 11, pp.e1004989~ (2015)
  27. Furuta Y, "Detection of varicella-zoster virus DNA in patients with acute peripheral facial palsy by the polymerase chain reaction, and its use for early diagnosis of zoster sine herpete", J Med Virol, 52, pp.316~319 (1997)
  28. Gershon AA, "The Jeremiah Metzger lecture varicella zoster virus : from outside to inside", Trans Am Clin Climatol Assoc, 127, pp.282~299 (2016)
  29. Gilden D, "Neurological disease produced by varicella zoster virus reactivation without rash", Curr Top Microbiol Immunol, 342, pp.243~253 (2010)
  30. Galetta KM, "Zeroing in on zoster : a tale of many disorders produced by one virus", J Neurol Sci, 358, pp.38~45 (2015)
  31. Kennedy PG, "Zoster sine herpete : it would be rash to ignore it", Neurology, 76, pp.416~417 (2011)
  32. Edelman DA, "Ogilvie syndrome and herpes zoster : case report and review of the literature", J Emerg Med, 39, pp.696~700 (2010)
  33. Gilden DH, "Zoster sine herpete, a clinical variant", Ann Neurol, 35, pp.530~533 (1994)
  34. Kasahara M, "A case of zoster sine herpete of the trigeminal nerve", Bull Tokyo Dent Coll, 52, pp.47~51 (2011)
  35. Hosseini S, "Atypical presentation of a common disease : shingles of the larynx", J Voice, 29, pp.600~602 (2015)
  36. Sengoku R, "Zoster sine herpete : detection by skin exudates and contrast magnetic resonance imaging", Eur Neurol, 67, pp.154~ (2012)
  37. Silverstein BE, "Disciform keratitis : a case of herpes zoster sine herpete", Am J Ophthalmol, 123, pp.254~255 (1997)
  38. Gershon AA, "Use of saliva to identify varicella zoster virus infection of the gut", Clin Infect Dis, 61, pp.536~544 (2015)
  39. Gershon AA, "Pathogenesis and current approaches to control of varicella-zoster virus infections", Clin Microbiol Rev, 26, pp.728~743 (2013)
  40. Leung J, "Evaluation of laboratory methods for diagnosis of varicella", Clin Infect Dis, 51, pp.23~32 (2010)
  41. Quinlivan M, "Use of oral fluid to examine the molecular epidemiology of varicella zoster virus in the United Kingdom and continental Europe", J Infect Dis, 207, pp.588~593 (2013)
  42. Pahud BA, "Varicella zoster disease of the central nervous system: epidemiological, clinical, and laboratory features 10 years after the introduction of the varicella vaccine", J Infect Dis, 203, pp.316~323 (2011)
  43. Papaevangelou V, "Subclinical VZV reactivation in immunocompetent children hospitalized in the ICU associated with prolonged fever duration", Clin Microbiol Infect, 19, pp.E245~51 (2013)
  44. Tecellioglu M, "A rare presentation of cranial polyneuropathy without rash caused by varicella zoster virus", Med Arch, 71, pp.293~295 (2017)
  45. Gershon AA, "The history and mystery of VZV in saliva", J Infect Dis, 204, pp.815~816 (2011)
  46. Park SY, "Relationships of varicella zoster virus(VZV)-specific cellmediated immunity and persistence of VZV DNA in saliva and the development of postherpetic neuralgia in patients with herpes zoster", J Med Virol, 91, pp.1995~2000 (2019)
  47. Nahass GT, "The clinical spectrum from classic varicella zoster to zoster sine herpete : the missing link", Arch Dermatol, 128, pp.1278~1279 (1992)
  48. Easton HG, "Zoster sine herpete causing acute trigeminal neuralgia", Lancet, 2, pp.1065~1066 (1970)
  49. Nagel MA, "Neurological complications of varicella zoster virus reactivation", Curr Opin Neurol, 27, pp.356~360 (2014)
  50. Vena GA, "Zoster ... “almost” ... sine herpete: diagnostic utility of real time-polymerase chain reaction", New Microbiol, 33, pp.409~410 (2010)
  51. Lee HY, "Zoster sine herpete causing facial palsy", Am J Otolaryngol, 33, pp.565~571 (2012)
  52. Furuta Y, "Early diagnosis of zoster sine herpete and antiviral therapy for the treatment of facial palsy", Neurology, 55, pp.708~710 (2000)
  53. Tamir B, "Burning pain from chest to backㆍallodynia and hyperesthesiaㆍextreme sensitivity at the left T5 dermatomeㆍDx?", J Fam Pract, 64, pp.E1~2 (2015)
  54. Morita Y, "Chronic active VZV infection manifesting as zoster sine herpete, zoster paresis and myelopathy", J Neurol Sci, 212, pp.7~9 (2003)
  55. Nagel MA, "The value of detecting anti-VZV IgG antibody in CSF to diagnose VZV vasculopathy", Neurology, 68, pp.1069~1073 (2007)
  56. Haug A, "Recurrent polymorphonuclear pleocytosis with increased red blood cells caused by varicella zoster virus infection of the central nervous system : case report and review of the literature", J Neurol Sci, 292, pp.85~88 (2010)
  57. Gilden D, "Recurrent varicella zoster virus myelopathy", J Neurol Sci, 276, pp.196~198 (2009)
  58. Blumenthal DT, "Zoster sine herpete : virologic verification by detection of anti-VZV IgG antibody in CSF", Neurology, 76, pp.484~485 (2011)
  59. Amlie-Lefond C, "Another case of virologically con-firmed zoster sine herpete, with electrophysiologic correlation", J Neurovirol, 2, pp.136~138 (1996)
  60. Gilden DH, "Neurologic complications of the reactivation of varicella-zoster virus", N Engl J Med, 342, pp.635~645 (2000)
  61. Pollak L, "Varicella-zoster DNA in saliva of patients with meningoencephalitis : a preliminary study", Acta Neurol Scand, 131, pp.417~421 (2015)
  62. Yamada S, "Ipsilateral truncal sensory deficit in a patient with ophthalmic zoster sine herpete", Neurology, 60, pp.1049~1050 (2003)
  63. Mantero V, "Varicella-zoster meningoencephaloradiculoneuropathy in an immunocompetent young woman", J Clin Virol, 57, pp.361~362 (2013)
  64. Spagnoli C, "Unusual trigeminal autonomic pain heralding hemichorea due to zoster sine Herpete vasculopathy", Pediatr Neurol, 49, pp.205~208 (2013)
  65. Persson A, "Varicella-zoster virus CNS disease--viral load, clinical manifestations and sequels", J Clin Virol, 46, pp.249~253 (2009)
  66. Dueland AN, "Fatal varicella-zoster virus meningoradiculitis without skin involvement", Ann Neurol, 29, pp.569~572 (1991)
  67. Kleinschmidt-DeMasters BK, "Varicella-zoster virus infections of the nervous system : clinical and pathologic correlates", Arch Pathol Lab Med, 125, pp.770~780 (2001)
  68. Philip A, "Post herpetic neuralgia", J Palliat Med, 14, pp.765~773 (2011)
  69. Hadley GR, "Post-herpetic neuralgia : a review", Curr Pain Headache Rep, 20, pp.17~ (2016)
  70. Harpaz R, "Prevention of herpes zoster : recommendations of the Advisory Committee on Immunization Practices(ACIP)", MMWR Recomm Rep, 57, pp.1~30 (2008)
  71. Dooling KL, "Recommendations of the Advisory Committee on Immunization Practices for use of herpes zoster vaccines", MMWR Morb Mortal Wkly Rep, 67, pp.103~108 (2018)
  72. Harpaz R, "The epidemiology of herpes zoster in the United States during the era of varicella and herpes zoster vaccines : changing patterns among older adults", Clin Infect Dis, 69, pp.341~344 (2019)
  73. Gan EY, "Management of herpes zoster and post-herpetic neuralgia", Am J Clin Dermatol, 14, pp.77~85 (2013)
  74. Hui F, "A randomized controlled trial of a multifaceted integrated complementary-alternative therapy for chronic herpes zoster-related pain", Altern Med Rev, 17, pp.57~68 (2012)
  75. Abdel-Aziz M, "The association of Varicella zoster virus reactivation with Bell’s palsy in children", Int J Pediatr Otorhinolaryngol, 79, pp.328~331 (2015)
  76. Argoff CE, "Review of current guidelines on the care of postherpetic neuralgia", Postgrad Med, 123, pp.134~142 (2011)
  77. Schlereth T, "Association between pain, central sensitization and anxiety in postherpetic neuralgia", Eur J Pain, 19, pp.193~201 (2015)
  78. McCarberg B, "Managing the comorbidities of postherpetic neuralgia", J Am Acad Nurse Pract, 15(12 Suppl), pp.16~21 (2003)
  79. Cao S, "Local brain activity differences between herpes zoster and postherpetic neuralgia patients : a resting-state functional MRI study", Pain Physician, 20, pp.E687~99 (2017)
  80. Cao S, "Herpes zoster chronification to postherpetic neuralgia induces brain activity and grey matter volume change", Am J Transl Res, 10, pp.184~199 (2018)
  81. Cao S, "Abnormal local brain activity beyond the pain matrix in postherpetic neuralgia patients : a resting-state functional MRI study", Pain Physician, 20, pp.E303~14 (2017)

이 간행물의 다른 논문 (12건)

The interpretation bias and trap of multicenter clinical researchDaehyun Jopp. 199-200Recombinant zoster vaccine (Shingrix®): a new option for the prevention of herpes zoster and postherpetic neuralgiaEunjoo Choi, Francis Sahngun Nahm, Sejin Song, Grisuna Singh, Pyung-Bok Leepp. 201-207Exploring the role and mechanisms of diallyl trisulfide and diallyl disulfide in chronic constriction-induced neuropathic pain in ratsChunfeng Wang, Ying Liu, Jianzhong Huang, Gang Wang, Yan Yang, Hao Wang, Xiao Wangpp. 216-225Comparison of treatment outcomes in lumbar central stenosis patients treated with epidural steroid injections: interlaminar versus bilateral transforaminal approachIpek Saadet Edipoglu, Osman Hakan Gunduz, Savas Sencan, Gunay Yolcu, Alp Eren Celenlioglupp. 226-233Patients’ perception about opioids and addiction in South KoreaSung Jun Hong, Jung Eun Kim, Yun Hee Lim, Jae Hun Jeong, Hey Ran Choi, Sun Kyung Park, Jae Hun Kim, Cho Long Kim, Ho Sik Moon, Hakjong Youpp. 234-244
원문 보기